Revenue and Profit - Revenue for the year ended December 31, 2024 was 2,674,000,anincreaseof591,000 or 28% compared to 2,083,000fortheyearendedDecember31,2023[101]−GrossprofitfortheyearendedDecember31,2024was376,000, an increase of 3,833,000comparedtoagrossdeficitof3,457,000 for the year ended December 31, 2023, resulting in a gross margin of 14%[103] Expenses - Research and development expenses for the year ended December 31, 2024 were 7,818,000,anincreaseof362,000 compared to 7,456,000fortheyearendedDecember31,2023[104]−SalesandmarketingexpensesfortheyearendedDecember31,2024were3,974,000, a decrease of 1,203,000comparedto5,177,000 for the year ended December 31, 2023[105] - General and administrative expenses for the year ended December 31, 2024 were 9,722,000,anincreaseof4,355,000 compared to 5,367,000fortheyearendedDecember31,2023[106]−InterestexpensefortheyearendedDecember31,2024was1,272,000 compared to 932,000fortheyearendedDecember31,2023[107]CashFlow−CashandcashequivalentsasofDecember31,2024were3,330,000, compared to 411,000asofDecember31,2023[115]−NetcashusedinoperatingactivitiesfortheyearendedDecember31,2024was17,526,000, compared to 14,826,000fortheyearendedDecember31,2023[116]OtherFinancialInformation−Thecompanyrecordedadeemeddividendof5,842,000 during the year ended December 31, 2024 related to the repurchase of Series B Preferred Stock shares[112] - The company expects operating losses to continue in the foreseeable future due to additional costs related to research and development and plans to expand its product portfolio[119]